Loading organizations...
Loading organizations...
Hua Nan Venture Capital operates as the dedicated venture capital arm of Hua Nan Financial Holdings, focusing its investments on companies demonstrating innovative technologies, novel concepts, and significant growth potential. The firm primarily targets early- and mid-stage high-tech startups and niche, high-growth enterprises. Its approach extends beyond capital provision, offering comprehensive nurturing and mentorship to guide portfolio companies through critical stages of development, from initial growth to potential mergers, acquisitions, and initial public offerings.
The venture capital entity emerged from the strategic diversification of Hua Nan Financial Holdings, which was established on December 19, 2001. This formation resulted from a share swap between the venerable Hua Nan Commercial Bank, founded in 1919 with leadership from figures like Mr. Lin Hsiung-Cheng, and EnTrust Securities, aimed at fulfilling Taiwan's financial holding company regulations. The venture capital arm was subsequently developed to extend the group's financial services into the burgeoning innovation ecosystem.
Hua Nan Venture Capital's clientele comprises ambitious startups and emerging technology firms seeking both financial backing and strategic guidance. The firm's long-term vision is to be a pivotal partner in fostering the development of pioneering companies, assisting them in achieving market leadership and navigating the complexities of scaling and capital markets. It aims to support the ecosystem of innovation by identifying and empowering the next generation of industry leaders.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 6, 2016 | ACT Genomics | $12.5M Series B | CDIB Capital, Hotung Venture Group | Eminent II Venture Capital, President International Development Corporation, UMC Capital |